Bleeding Prophylaxis in Bleeding Disorder Patients Undergoing GI Endoscopy

Publication Date: March 16, 2020

Key Points

Key Points

  • Low risk procedures like gastroscopy or colonoscopy without polypectomy have a bleeding risk between 0 and 0.02%.
  • In general, a number of variables increases the risk of bleeding, independent of an underlying bleeding disorder, including older age, male gender, polypectomy >7 mm, and colonoscopy performed by a low-volume endoscopist. The continued development of endoscopes and equipment is likely to reduce the bleeding risk further.
  • Three recent studies have provided detailed information on best prophylaxis practice for patients with bleeding disorders.
    • Infusing to a higher target of 80–100% and using concurrent tranexamic acid pre-procedure should be incorporated in any recommendations as well as infusing for 7–10 days if a high-risk procedure.

Treatment

...atment...

...All Bleeding Disorder...

...re-treatment with antifibrinolytic therapy,*...


...Moderate or Severe Hemophilia or Severe VWD on...

...moving the prophylactic factor dose...


...or the Non-inhibitor Hemophilia a Patient...

Advise infusing with FVIII to goal 80–10...


...hibitor Hemophilia a Patient on Emicizumab...

...pre-procedure 90–120 mcg/kg and repeat t...


...nown DDAVP Responsive Type 1 VWD, Low VWF or Mild...

...ster IN or IV DDAVP 60–90 min pre-proce...


...ic Variceal Ligation or Hemorrhoidectomy...

...pre-dose and continue to infuse daily × 7 days.67...


...ld Platelet Function Disorders...

...IN/IV DDAVP 60–90 min pre-procedure and repeat...


...re Platelet Function Disorders (Glanzmann Thromba...

...ster rVIIa 90–120 mcg/kg then q2...


...merican Society of Gastrointestinal Endosc...

...Procedures Diagnostic endoscopy (EGD, co...

...r Risk Procedures Polypectomy Biliary o...